These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 695651)
1. [Haemodynamic response to antihypertensive treatment with atenolol in patients with hypertension (author's transl]. Zilcher H; Glogar D; Uhlir H; Leisch F; Niederberger M; Steinbach K Wien Klin Wochenschr; 1978 Sep; 90(16):611-6. PubMed ID: 695651 [TBL] [Abstract][Full Text] [Related]
2. Comparison of central and peripheral haemodynamic effects of dilevalol and atenolol in essential hypertension. Tham TC; Silke B; Taylor SH J Hum Hypertens; 1990 Jun; 4 Suppl 2():77-83. PubMed ID: 2370647 [TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of atenolol in labile hypertension. González-Gómez A; García-Barreto D; Fránquiz JM Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):260-7. PubMed ID: 6838285 [TBL] [Abstract][Full Text] [Related]
4. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension. Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364 [TBL] [Abstract][Full Text] [Related]
5. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension. Saner H; Seiler A; Mahler F Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224 [TBL] [Abstract][Full Text] [Related]
6. Predictive value of various parameters for the antihypertensive effect of the beta blocker ICI 66,082 (1). Meekers J; Missotten A; Fagard R; Demuynck D; Harvengt C; Pas P; Billiet L; Amery A Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):294-306. PubMed ID: 238480 [TBL] [Abstract][Full Text] [Related]
7. Changes in left ventricular anatomy and systemic hemodynamics induced by antihypertensive therapy with indenolol. De Luca N; Ricciardelli B; Groothold G; Cuocolo A; Volpe M; Trimarco B J Clin Hypertens; 1987 Jun; 3(2):125-34. PubMed ID: 2956371 [TBL] [Abstract][Full Text] [Related]
8. [The effect of atenolol on contractility and hemodynamics of the infarcted heart in comparison to propranolol and practolol (author's transl)]. Stephan K; Meesmann W; Bischoff KO; Hübner H; Geigenmüller L; Diesch J Arzneimittelforschung; 1975 Nov; 25(11):1770-6. PubMed ID: 1243085 [TBL] [Abstract][Full Text] [Related]
9. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension. O'Connor DT; Mosley CA; Cervenka J; Bernstein KN J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882 [TBL] [Abstract][Full Text] [Related]
10. Long-term haemodynamic effects of enalapril (alone and in combination with hydrochlorothiazide) at rest and during exercise in essential hypertension. Lund-Johansen P; Omvik P J Hypertens Suppl; 1984 Dec; 2(2):S49-56. PubMed ID: 6100877 [TBL] [Abstract][Full Text] [Related]
11. [Mechanics of circulation in lowering the blood pressure in different hemodynamic forms of hypertension (author's transl)]. Schäfer N; Härich BK; Hansen B; Stauch M Med Klin; 1976 Jan; 71(5):205-12. PubMed ID: 814397 [TBL] [Abstract][Full Text] [Related]
12. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade. Leenen FH; Davies RA; Fourney A Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044 [TBL] [Abstract][Full Text] [Related]
13. [Atenolol in the treatment of premature ventricular contractions. A double blind study in 68 patients (author's transl)]. Körst HA; Brandes JW; Lembcke HJ; Littmann KP Z Kardiol; 1981 May; 70(5):419-24. PubMed ID: 6168124 [TBL] [Abstract][Full Text] [Related]
14. Haemodynamic effects of propranolol in hypertension: a review. Tarazi RC; Dustan HP; Bravo EL Postgrad Med J; 1976; 52 Suppl 4():92-100. PubMed ID: 787955 [TBL] [Abstract][Full Text] [Related]
15. Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension. Lund-Johansen P Br J Clin Pharmacol; 1976 Jun; 3(3):445-51. PubMed ID: 973971 [TBL] [Abstract][Full Text] [Related]
16. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension. Man in't Veld AJ; Schalekamp MA Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800 [TBL] [Abstract][Full Text] [Related]
17. Comparative effects of atenolol and cicloprolol on cardiac performance in coronary heart disease. Silke B; Verma SP; Sharma SK; Frais MA; Reynolds G; Taylor SH J Cardiovasc Pharmacol; 1989 Jan; 13(1):155-61. PubMed ID: 2468927 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the effect of obsidan in essential hypertension patients with different types of circulation]. Goloshchapov OA; Pribylova NN; Kotova LN; Nozhnova LP Ter Arkh; 1986; 58(11):29-32. PubMed ID: 3824185 [TBL] [Abstract][Full Text] [Related]
19. Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients. Simon G; Franciosa JA; Gimenez HJ; Cohn JN Hypertension; 1981; 3(2):262-8. PubMed ID: 6111532 [TBL] [Abstract][Full Text] [Related]
20. [Atenolol, a new beta-adrenergic blocking agent, in treatment of hypertension: therapeutic effect and hemodynamic changes (author's transl)]. Shen JQ Zhonghua Xin Xue Guan Bing Za Zhi; 1981 Jun; 9(2):94-8. PubMed ID: 7032869 [No Abstract] [Full Text] [Related] [Next] [New Search]